Severe spinal cord injuries affect millions of people worldwide, often resulting in long-term and debilitating consequences. Much of the damage comes not only from the initial trauma but also from degenerative processes that follow. However, researchers at Washington University School of Medicine in St. Louis have made remarkable progress in developing an immunotherapy that may help minimize this secondary damage. Their study, published in Nature, highlights how immunotherapy could protect neurons at the injury site from harmful immune cell attacks, providing new hope for improving recovery outcomes in individuals with spinal cord injuries.
“Immune cells in the central nervous system have a reputation for being the bad guys that can harm the brain and spinal cord,” explained Jonathan Kipnis, PhD, the Alan A. and Edith L. Wolff Distinguished Professor of Pathology & Immunology at WashU Medicine. “But our study shows it’s possible to harness the neuroprotective functions of these cells while controlling their harmful tendencies to aid in the recovery from central nervous system injuries.”
Continue reading… “Breakthrough Immunotherapy Offers Hope for Spinal Cord Injury Recovery”
